pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 3
nivolumab biosimilar
Bladder Cancer
Xbrane Biopharma AB
0 catalysts
Marketed
nizatidine
Nizatidine (nizatidine)
Acid Indigestion (Heartburn/Pyrosis)
Epic Pharma LLC
0 catalysts
Phase 3
nizubaglustat
nizubaglustat [INN]
GM1 Gangliosidosis (Beta Galactosidase 1 Deficiency)
Azafaros BV
0 catalysts
Phase 3
← prev
page 200 of 231
next →
131
Pain89
Neurology1
nofazinlimab
nofazinlimab [INN]
Hepatocellular Carcinoma
CStone Pharmaceuticals Co Ltd
0 catalysts
pre_registration
nogapendekin alfa
Anktiva (nogapendekin alfa)
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
$IBRXImmunityBio, Inc.
0 catalysts
Phase 2
nomlabofusp
Friedreich Ataxia
$LRMRLarimar Therapeutics, Inc.
0 catalysts
Phase 3
norelgestromin
Female Contraception
Progesterone receptor
$VTRSViatris Inc
0 catalysts
Marketed
norethindrone
Norethindrone (norethindrone)
Female Contraception
Naari USA Inc
0 catalysts
Marketed
norgestrel
Opill (norgestrel)
Female Contraception
HRA Pharma LLC
0 catalysts
Phase 1
norovirus [strain GI.1] vaccine
Norovirus Infections
$VXRTVaxart, Inc.
0 catalysts
Marketed
north american coral snake [Micrurus fulvius] antivenom [equine]
Antivenin (Micrurus fulvius)
Poisoning
$PFEPFIZER INC
0 catalysts
Marketed
nortriptyline hydrochloride
Nortriptyline Hydrochloride (nortriptyline hydrochloride)
Depression
PAI Holding Co LLC
0 catalysts
Phase 3
nucresiran
nucresiran [INN]
Familial Amyloid Cardiomyopathy
$ALNYALNYLAM PHARMACEUTICALS, INC.
0 catalysts
Phase 2
nulabeglogene autogedtemcel
Sickle Cell Disease
Kamau Therapeutics Inc
0 catalysts
Marketed
nusinersen
Spinraza (nusinersen)
Spinal Muscular Atrophy (SMA)
$BIIBBIOGEN INC.
0 catalysts
Phase 2
nuvisertib hydrochloride
Secondary Myelofibrosis
Sumitomo Pharma America Inc
0 catalysts
Phase 2
nuzefatide pevedotin
nuzefatide pevedotin [INN]
Gastric Cancer
$BCYCBICYCLE THERAPEUTICS PLC
0 catalysts
Marketed
nystatin
Nystatin (nystatin [INN])
Chronic Mucocutaneous Candidiasis
Actavis Mid Atlantic LLC
0 catalysts
Phase 3
obecabtagene autoleucel
Aucatzyl (obecabtagene autoleucel)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
B-lymphocyte antigen CD19
$AUTLAutolus Therapeutics plc
0 catalysts
Phase 3
obefazimod
Ulcerative Colitis
Cap binding complex
Abivax SA
0 catalysts
Phase 1
oberotatug ravtansine
Adenoid Cystic Carcinoma (ACC)
Oxford BioTherapeutics Ltd
0 catalysts
Phase 3
obexelimab
Immunoglobulin G4-Related Disease (IgG4-RD)
B-lymphocyte antigen CD19Low affinity immunoglobulin gamma Fc region receptor II-b
$ZBIOZenas BioPharma, Inc.
0 catalysts
Phase 3
obicetrapib calcium
Heterozygous Familial Hypercholesterolemia (heFH)
NewAmsterdam Pharma Company NV
0 catalysts
Marketed
obiltoxaximab
Anthim (obiltoxaximab)
Anthrax
Elusys Therapeutics Inc
0 catalysts
Phase 2
obrixtamig
obrixtamig [INN]
Small-Cell Lung Cancer
Boehringer Ingelheim International GmbH
0 catalysts
Phase 3
obudanersen sodium
Angelman Syndrome
$IONSIONIS PHARMACEUTICALS INC
0 catalysts
Phase 2
ocifisertib
ocifisertib [INN]
Refractory Acute Myeloid Leukemia
Treadwell Therapeutics Inc
0 catalysts
Marketed
ocrelizumab
Ocrevus (ocrelizumab)
Primary Progressive Multiple Sclerosis (PPMS)
Genentech Inc
0 catalysts
Phase 3
ocrelizumab biosimilar
Relapsing Remitting Multiple Sclerosis (RRMS)
Celltrion Inc
0 catalysts
pre_registration
octreotide LA
Oclaiz (octreotide)
Acromegaly
Somatostatin receptor
Camurus AB
0 catalysts